Commentary & Reports For: (OTC:BMSN), (OTC:FNMAS)
RegenBioPharma, Inc. (Regen), a wholly-owned subsidiary of Bio-Matrix Scientific Group, Inc. (OTCQB: BMSN), provided an update on the Company's progress with HemaXellerate and other new developments.
View full press release